« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5
, Pages 1109-1115.e2
, May 2009
Seven-year results with the St Jude Medical Silzone mechanical prosthesis
References
- Para-prosthetic leak and other events in Silzone-coated mechanical heart valves: a report from AVERT. Ann Thorac Surg. 2002;73:785–792
- . Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, ad hoc liaison committee for standardizing definitions of prosthetic heart valve morbidity. Ann Thorac Surg. 1996;62:932–935
- . Artificial valve endocarditis reduction trial (AVERT): protocol of a multicenter randomized trial. J Heart Valve Dis. 1999;8:131–139
- . Recurrent endocarditis in silver-coated heart valve prosthesis. J Heart Valve Dis. 1999;8:140–142
- Early investigation of silver-coated Silzone heart valves prosthesis in 126 patients. J Heart Valve Dis. 2001;10:717–723
- . Silzone coating and para-prosthetic leak: an independent, randomized study. J Heart Valve Dis. 2001;10:712–715discussion 715-6
- . Incidence of embolism and paravalvar leak after St Jude Silzone valve implantation: Experience from the Cardiff embolic risk factor study. Heart. 2003;89:1055–1061
- . Thrombogenicity and reoperation of the St. Jude Medical Silzone valve: a comparison with the conventional St. Jude Medical valve. J Heart Valve Dis. 2003;12:635–639
- Importance of implant technique on risk of major para-prosthetic leak (PVL) after St. Jude mechanical heart valve replacement: a report from the artificial valve endocarditis reduction trial (AVERT). Eur J Cardiothorac Surg. 2005;28:838–843
- Para-prosthetic leak and other events in Silzone-coated mechanical heart valves: a report from AVERT. AVERT Investigators Report. Pittsburgh: University of Pittsburgh Coordinating Center; 2005;
- FDA Replacement Heart Valves Draft Guidance, Version 4.1. Washington, D.C.: U.S. Department of Health and Human Services; 1994;
- . Sample size requirements for evaluating heart valves with constant risk events. J Heart Valve Dis. 1994;3:53–58
- . Time-related risk of the St. Jude Silzone heart valve. Eur J Cardiothorac Surg. 2006;30:20–27
- Prevalence and severity of para-prosthetic regurgitation in the artificial valve endocarditis reduction trial (AVERT) echocardiography study. J Am Coll Cardiol. 2004;44:1467–1472
- . Thrombogenicity of the St. Jude Medical prosthesis with and without Silzone-coated sewing cuffs. Ann Thorac Surg. 2001;71:1065
- ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2006;48:e1–e148
- Surgical management of valvular heart disease 2004. Can J Cardiol. 2004;20(suppl E):7E–120E
Presented to the World Society of Cardio-Thoracic Surgery, Ottawa, Canada, August 17 to 20, 2006.
PII: S0022-5223(08)02196-X
doi: 10.1016/j.jtcvs.2008.07.070
© 2009 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 5
, Pages 1109-1115.e2
, May 2009
